Skip to content

Long-Term Follow-up Study of Subjects With Knee Osteoarthritis Who Had Administered FURESTEM-OA Kit Inj. in K0701 Study

Long-Term Follow-up Study of Subjects With Knee Osteoarthritis Who Had Administered FURESTEM-OA Kit Inj. in K0701 Study

Status
Not yet recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06013306
Enrollment
58
Registered
2023-08-28
Start date
2023-09-14
Completion date
2030-12-30
Last updated
2023-08-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Knee Osteoarthritis

Brief summary

Long-Term Follow-up Study of Subjects with Knee Osteoarthritis who had administered FURESTEM-OA Kit Inj. in K0701 study

Interventions

None listed

Sponsors

Kang Stem Biotech Co., Ltd.
Lead SponsorINDUSTRY

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
19 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Those who participated in the K0701 clinical trial and received PureStem-OA Kit Inj * Those who understand and voluntarily sign an informed consent form

Exclusion criteria

* None

Design outcomes

Primary

MeasureTime frame
Number of AESI5 years follow-up after treatment
Number of SS5 years follow-up after treatment

Secondary

MeasureTime frameDescription
Changes in 100-mm VAS1 year (52 weeks), 2 years (104 weeks), and 3 years (156 weeks) after treatment
Changes in International Knee Documentation Committee Scoring System (IKDC)1 year (52 weeks), 2 years (104 weeks), and 3 years (156 weeks) after treatmentA higher score indicates better function and less symptomatic
Changes in Knee Injury and Osteoarthritis Outcome Score (KOOS)1 year (52 weeks), 2 years (104 weeks), and 3 years (156 weeks) after treatmentThe higher the score, the worse the condition of the disease is.
Magnetic Resonance Observation of Cartilage Repair Tissue (MOCART) scores(MRI)1 year (52 weeks), 2 years (104 weeks), and 3 years (156 weeks) after treatmentA higher score indicates better function and less symptomatic
Whole-Organ Magnetic Resonance Imaging Score (WORMS) score1 year (52 weeks), 2 years (104 weeks), and 3 years (156 weeks) after treatmentThe higher the score means normal state.
Evaluation of International K&L grade(X-ray)1 year (52 weeks), 2 years (104 weeks), and 3 years (156 weeks) after treatmentGrade 0 - No radioligical findings of osteoarthritis Grade 1 - Doubtful narrowing of joint space and possible osteophytic lipping Grade 2 - Definite osteophytes and possible narrowing of joint space Grade 3 - Moderate osteophytes, definite narrowing of joint space, and some sclerosis and deformity of bone ends Grade 4 - Large osteophytes, marked narrowing of joint space, severe sclerosis, and definite deformity of bone ends
Changes in Western Ontario and McMaster Universities osteoarthritis index (WOMAC)1 year (52 weeks), 2 years (104 weeks), and 3 years (156 weeks) after treatmentThe WOMAC evaluation is evaluated using the score value converted through the KOOS evaluation paper.

Contacts

Primary ContactChaeeun JEON
cejeon@kangstem.com02-2036-7614
Backup ContactHyeseung JEON
hsjeon@kangstem.com02-888-1592

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026